Granahan Investment Management, LLC Karyopharm Therapeutics Inc. Transaction History

Granahan Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.45 - $10.63 $3.26 Million - $7.78 Million	-731,558 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$8.11 - $11.11 $333,710 - $457,154	41,148 Added 5.96%	731,558 $7.55 Million
Q1 2021 May 17, 2021	BUY	$9.85 - $17.69 $1.85 Million - $3.32 Million	187,868 Added 37.38%	690,410 $7.26 Million
Q4 2020 Feb 12, 2021	BUY	$14.15 - $17.19 $3.32 Million - $4.04 Million	234,845 Added 87.73%	502,542 $7.78 Million
Q3 2020 Nov 12, 2020	SELL	$14.14 - $19.71 $2.41 Million - $3.36 Million	-170,384 Reduced 38.89%	267,697 $3.91 Million
Q2 2020 Aug 14, 2020	BUY	$16.6 - $25.25 $7.27 Million - $11.1 Million	438,081 New	438,081 $8.3 Million

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $64.6M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Granahan Investment Management, LLC with notifications on news.